Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 4
1997 2
1998 3
1999 5
2000 8
2001 3
2002 10
2003 10
2004 8
2005 13
2006 7
2007 16
2008 14
2009 14
2010 11
2011 12
2012 11
2013 14
2014 15
2015 14
2016 13
2017 8
2018 10
2019 12
2020 16
2021 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Inhibitors-Recent insights.
Pratt KP, Arruda VR, Lacroix-Desmazes S. Pratt KP, et al. Among authors: lacroix desmazes s. Haemophilia. 2021 Feb;27 Suppl 3:28-36. doi: 10.1111/hae.14077. Epub 2020 Jun 30. Haemophilia. 2021. PMID: 32608138 Review.
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
Leborgne C, Barbon E, Alexander JM, Hanby H, Delignat S, Cohen DM, Collaud F, Muraleetharan S, Lupo D, Silverberg J, Huang K, van Wittengerghe L, Marolleau B, Miranda A, Fabiano A, Daventure V, Beck H, Anguela XM, Ronzitti G, Armour SM, Lacroix-Desmazes S, Mingozzi F. Leborgne C, et al. Among authors: lacroix desmazes s. Nat Med. 2020 Jul;26(7):1096-1101. doi: 10.1038/s41591-020-0911-7. Epub 2020 Jun 1. Nat Med. 2020. PMID: 32483358 Free article.
Noncanonical Functions of Antibodies.
Dimitrov JD, Lacroix-Desmazes S. Dimitrov JD, et al. Among authors: lacroix desmazes s. Trends Immunol. 2020 May;41(5):379-393. doi: 10.1016/j.it.2020.03.006. Epub 2020 Apr 6. Trends Immunol. 2020. PMID: 32273170 Review.
Tolerating Factor VIII: Recent Progress.
Lacroix-Desmazes S, Voorberg J, Lillicrap D, Scott DW, Pratt KP. Lacroix-Desmazes S, et al. Front Immunol. 2020 Jan 10;10:2991. doi: 10.3389/fimmu.2019.02991. eCollection 2019. Front Immunol. 2020. PMID: 31998296 Free PMC article. Review.
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Bou-Jaoudeh M, Mimoun A, Delignat S, Peyron I, Capdevila L, Daventure V, Deligne C, Dimitrov JD, Christophe OD, Denis CV, Lenting PJ, Proulle V, Lacroix-Desmazes S. Bou-Jaoudeh M, et al. Among authors: lacroix desmazes s. J Thromb Haemost. 2023 Oct;21(10):2776-2783. doi: 10.1016/j.jtha.2023.06.038. Epub 2023 Jul 18. J Thromb Haemost. 2023. PMID: 37473843 Free article.
The antiinflammatory IgG.
Kaveri SV, Lacroix-Desmazes S, Bayry J. Kaveri SV, et al. Among authors: lacroix desmazes s. N Engl J Med. 2008 Jul 17;359(3):307-9. doi: 10.1056/NEJMcibr0803649. N Engl J Med. 2008. PMID: 18635437 No abstract available.
Immunogenicity of long-lasting recombinant factor VIII products.
Ing M, Gupta N, Teyssandier M, Maillère B, Pallardy M, Delignat S, Lacroix-Desmazes S; ABIRISK consortium. Ing M, et al. Among authors: lacroix desmazes s. Cell Immunol. 2016 Mar;301:40-8. doi: 10.1016/j.cellimm.2015.12.006. Epub 2015 Dec 19. Cell Immunol. 2016. PMID: 26723503 Free article. Review.
236 results